| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vivax malaria in Mauritania includes infection of a Duffy-negative individual.
|
Malar J
|
2011
|
1.63
|
|
2
|
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.
|
Antimicrob Agents Chemother
|
2009
|
1.59
|
|
3
|
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2007
|
1.33
|
|
4
|
Molecular detection of Bartonella quintana, B. Elizabethae, B. Koehlerae, B. Doshiae, B. Taylorii, and Rickettsia felis in rodent fleas collected in Kabul, Afghanistan.
|
Am J Trop Med Hyg
|
2006
|
1.24
|
|
5
|
Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests.
|
Malar J
|
2013
|
1.23
|
|
6
|
The use of remotely sensed environmental data in the study of malaria.
|
Geospat Health
|
2011
|
1.22
|
|
7
|
Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.
|
J Antimicrob Chemother
|
2011
|
1.19
|
|
8
|
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.
|
Antimicrob Agents Chemother
|
2011
|
1.10
|
|
9
|
Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria.
|
Antimicrob Agents Chemother
|
2009
|
1.10
|
|
10
|
Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania.
|
Trans R Soc Trop Med Hyg
|
2011
|
1.10
|
|
11
|
Antimalarial drug use in general populations of tropical Africa.
|
Malar J
|
2008
|
1.09
|
|
12
|
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2008
|
1.06
|
|
13
|
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
|
Malar J
|
2012
|
1.06
|
|
14
|
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
|
Malar J
|
2013
|
1.05
|
|
15
|
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.
|
Malar J
|
2010
|
1.05
|
|
16
|
Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene.
|
J Antimicrob Chemother
|
2010
|
1.04
|
|
17
|
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
|
Malar J
|
2013
|
0.96
|
|
18
|
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.
|
Malar J
|
2015
|
0.95
|
|
19
|
High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
|
Am J Trop Med Hyg
|
2009
|
0.94
|
|
20
|
Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatin.
|
Antimicrob Agents Chemother
|
2012
|
0.92
|
|
21
|
Mosquito magnet® liberty plus trap baited with octenol confirmed best candidate for Anopheles surveillance and proved promising in predicting risk of malaria transmission in French Guiana.
|
Malar J
|
2014
|
0.92
|
|
22
|
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
|
Malar J
|
2013
|
0.92
|
|
23
|
Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2011
|
0.91
|
|
24
|
Malaria in French Guiana Linked to Illegal Gold Mining.
|
Emerg Infect Dis
|
2016
|
0.91
|
|
25
|
Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.
|
Malar J
|
2010
|
0.91
|
|
26
|
Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
|
Antimicrob Agents Chemother
|
2013
|
0.90
|
|
27
|
Population genetics analysis during the elimination process of Plasmodium falciparum in Djibouti.
|
Malar J
|
2013
|
0.90
|
|
28
|
Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.
|
Antimicrob Agents Chemother
|
2009
|
0.90
|
|
29
|
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.
|
Malar J
|
2012
|
0.90
|
|
30
|
Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants.
|
Malar J
|
2012
|
0.89
|
|
31
|
Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa.
|
Malar J
|
2011
|
0.87
|
|
32
|
Malaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana.
|
Emerg Infect Dis
|
2016
|
0.86
|
|
33
|
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.
|
Malar J
|
2013
|
0.84
|
|
34
|
Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.
|
Malar J
|
2012
|
0.83
|
|
35
|
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal.
|
Malar J
|
2013
|
0.82
|
|
36
|
Anopheles salivary gland proteomes from major malaria vectors.
|
BMC Genomics
|
2012
|
0.80
|
|
37
|
Plasmodium falciparum with multidrug resistance 1 gene duplications, Senegal.
|
Emerg Infect Dis
|
2013
|
0.76
|
|
38
|
[Antiparasitic vaccines: where are we now?].
|
Rev Prat
|
2007
|
0.75
|
|
39
|
Zika Virus Persistence and Higher Viral Loads in Cutaneous Capillaries Than in Venous Blood.
|
Emerg Infect Dis
|
2017
|
0.75
|
|
40
|
Expression and biochemical characterization of the Plasmodium falciparum protein kinase A catalytic subunit.
|
Parasitol Res
|
2009
|
0.75
|